EyeBOX (Model EBX-4)— 510(k) K212310

Substantially Equivalent

Oculogica, Inc.

FDA 510(k) clearance K212310 for EyeBOX (Model EBX-4), Substantially Equivalent on 2021-12-22. Applicant: Oculogica, Inc..

Clearance details

Applicant: Oculogica, Inc.
Product code: Code QEA
Advisory panel: Neurology
Date received: 2021-07-23
Decision date: 2021-12-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: New York, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.